Abbott launches drug stent

LIBERTYVILLE TOWNSHIP - Abbott announced the widespread availability of its next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. XIENCE PRIME offers a novel stent design and a delivery system designed for greater flexibility and enhanced deliverability. XIENCE PRIME is widely available in Europe and select countries throughout Asia-Pacific and Latin America.